acrolein has been researched along with zidovudine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barker, DF; Barve, SS; Chen, WY; Donde, H; Ghare, SS; Gobejishvilli, L; Joshi-Barve, S; McClain, CJ | 1 |
2 other study(ies) available for acrolein and zidovudine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Acrolein enhances epigenetic modifications, FasL expression and hepatocyte toxicity induced by anti-HIV drug Zidovudine.
Topics: Acrolein; Animals; Anti-HIV Agents; Apoptosis; Cell Survival; Cells, Cultured; DNA Fragmentation; Epigenesis, Genetic; Fas Ligand Protein; Hep G2 Cells; Hepatocytes; Histones; Humans; Hydralazine; Rats; RNA Polymerase II; Zidovudine | 2016 |